Intrathecal Synthesis of Immunoglobulins G: Is it associated with the severity of Relapsing-Remitting Multiple Sclerosis?

被引：0
|
作者：
Mouloudi, Najoua [1 ]
Ben Moh, Youssouf [1 ]
Bourazza, Ahmed [1 ]
机构：
[1] Mohamed V Mil Training Hosp, Dept Neurol & Clin Neurophysiol, Rabat, Morocco
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1843/4208
引用
收藏
页码：1234 / 1234
页数：1
相关论文
共 50 条
  • [31] Relapsing-remitting multiple sclerosis and subclinical atherosclerosis
    Omerzu, T.
    Magdic, J.
    Hojs, R.
    Fabjan, T. Hojs
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 376 - 377
  • [32] Cladribine Tablets In Relapsing-Remitting Multiple Sclerosis
    Muir, Victoria J.
    Plosker, Greg L.
    CNS DRUGS, 2011, 25 (03) : 239 - 249
  • [33] Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
    Buscarinu, M. C.
    Romano, S.
    Mechelli, R.
    Umeton, R. Pizzolato
    Ferraldeschi, M.
    Fornasiero, A.
    Renie, R.
    Cerasoli, B.
    Morena, E.
    Romano, C.
    Loizzo, N. D.
    Umeton, R.
    Salvetti, M.
    Ristori, G.
    NEUROTHERAPEUTICS, 2018, 15 (01) : 68 - 74
  • [34] Cognitive Resilience in Relapsing-Remitting Multiple Sclerosis
    Achiron, Anat
    Harel, Yermi
    Lavie, Mor
    Simon, Ely S.
    Doniger, Glen M.
    NEUROLOGY, 2010, 74 (09) : A162 - A162
  • [35] Resistance Training in Relapsing-Remitting Multiple Sclerosis
    Dalgas, U.
    Kant, M.
    Stenager, E.
    AKTUELLE NEUROLOGIE, 2010, 37 (05) : 213 - 218
  • [36] INSOMNIA SYMPTOM SEVERITY AND QUALITY OF LIFE IN PERSONS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Culnan, E.
    Tessier, J.
    Grunberg, V
    Morse, C.
    Germain, A.
    Schultheis, M.
    Kloss, J. D.
    SLEEP, 2018, 41 : A383 - A383
  • [37] Health care costs and disease severity of relapsing-remitting multiple sclerosis in Portugal
    Pereira, J
    Mateus, C
    de Sá, J
    Rio, ME
    Monteiro, E
    Matias, F
    Bravo-Marques, J
    Figueiredo, J
    Bigotte, L
    Gonçalves, L
    Pedrosa, R
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S135 - S135
  • [38] An update on cladribine for relapsing-remitting multiple sclerosis
    Holmoy, Trygve
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
  • [39] Therapeutic inertia in relapsing-remitting multiple sclerosis
    Rodrigues, Rita
    Rocha, Raquel
    Bonifacio, Goncalo
    Ferro, Daniela
    Sabenca, Francisco
    Goncalves, Ana Isabel
    Correia, Filipe
    Pinheiro, Joaquim
    Loureiro, Jose Leal
    Guerreiro, Rui Pedro
    Vale, Jose
    Sa, Maria Jose
    Costa, Andreia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55
  • [40] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
12345